Download
s00406-020-01175-2.pdf 776,66KB
WeightNameValue
1000 Titel
  • Aerobic endurance training to improve cognition and enhance recovery in schizophrenia: design and methodology of a multicenter randomized controlled trial
1000 Autor/in
  1. Maurus, Isabel |
  2. Hasan, Alkomiet |
  3. Schmitt, Andrea |
  4. Roeh, Astrid |
  5. Keeser, Daniel |
  6. Malchow, Berend |
  7. Schneider-Axmann, Thomas |
  8. Hellmich, Martin |
  9. Schmied, Sabine |
  10. Lembeck, Moritz |
  11. Keller-Varady, Katriona |
  12. Papazova, Irina |
  13. Hirjak, Dusan |
  14. Topor, Cristina E. |
  15. Walter, Henrik |
  16. Mohnke, Sebastian |
  17. Vogel, Bob O. |
  18. Wölwer, Wolfgang |
  19. Schneider, Frank |
  20. Henkel, Karsten |
  21. Meyer-Lindenberg, Andreas |
  22. Falkai, Peter |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-03
1000 Erschienen in
1000 Quellenangabe
  • 271(2):315-324
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00406-020-01175-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257533/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Even today, patients with schizophrenia often have an unfavorable outcome. Negative symptoms and cognitive deficits are common features in many patients and prevent recovery. In recent years, aerobic endurance training has emerged as a therapeutic approach with positive effects on several domains of patients' health. However, appropriately sized, multicenter randomized controlled trials that would allow better generalization of results are lacking. The exercise study presented here is a multicenter, rater-blind, two-armed, parallel-group randomized clinical trial in patients with clinically stable schizophrenia being conducted at five German tertiary hospitals. The intervention group performs aerobic endurance training on bicycle ergometers three times per week for 40-50 min/session (depending on the intervention week) for a total of 26 weeks, and the control group performs balance and tone training for the same amount of time. Participants are subsequently followed up for 26 weeks. The primary endpoint is all-cause discontinuation; secondary endpoints include psychopathology, cognition, daily functioning, cardiovascular risk factors, and explorative biological measures regarding the underlying mechanisms of exercise. A total of 180 patients will be randomized. With currently 162 randomized participants, our study is the largest trial to date to investigate endurance training in patients with schizophrenia. We hypothesize that aerobic endurance training has beneficial effects on patients' mental and physical health, leading to lower treatment discontinuation rates and improving disease outcomes. The study results will provide a basis for recommending exercise interventions as an add-on therapy in patients with schizophrenia.The study is registered in the International Clinical Trials Database (ClinicalTrials.gov identifier [NCT number]: NCT03466112) and in the German Clinical Trials Register (DRKS-ID: DRKS00009804). (c) Springer-Verlag GmbH Germany
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Randomized clinical trial
lokal Randomized Controlled Trials as Topic/methods [MeSH]
lokal Middle Aged [MeSH]
lokal Schizophrenia
lokal Endurance Training [MeSH]
lokal Research Design [MeSH]
lokal Exercise
lokal Male [MeSH]
lokal Data Interpretation, Statistical [MeSH]
lokal Original Paper
lokal Physical activity
lokal Young Adult [MeSH]
lokal Psychiatric Rehabilitation [MeSH]
lokal Single-Blind Method [MeSH]
lokal Recovery
lokal Outcome Assessment, Health Care [MeSH]
lokal Schizophrenia/rehabilitation [MeSH]
lokal Cognition
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-6208-5180|https://frl.publisso.de/adhoc/uri/SGFzYW4sIEFsa29taWV0|https://frl.publisso.de/adhoc/uri/U2NobWl0dCwgQW5kcmVh|https://frl.publisso.de/adhoc/uri/Um9laCwgQXN0cmlk|https://frl.publisso.de/adhoc/uri/S2Vlc2VyLCBEYW5pZWw=|https://frl.publisso.de/adhoc/uri/TWFsY2hvdywgQmVyZW5k|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLUF4bWFubiwgVGhvbWFz|https://frl.publisso.de/adhoc/uri/SGVsbG1pY2gsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/U2NobWllZCwgU2FiaW5l|https://frl.publisso.de/adhoc/uri/TGVtYmVjaywgTW9yaXR6|https://frl.publisso.de/adhoc/uri/S2VsbGVyLVZhcmFkeSwgS2F0cmlvbmE=|https://frl.publisso.de/adhoc/uri/UGFwYXpvdmEsIElyaW5h|https://frl.publisso.de/adhoc/uri/SGlyamFrLCBEdXNhbg==|https://frl.publisso.de/adhoc/uri/VG9wb3IsIENyaXN0aW5hIEUu|https://frl.publisso.de/adhoc/uri/V2FsdGVyLCBIZW5yaWs=|https://frl.publisso.de/adhoc/uri/TW9obmtlLCBTZWJhc3RpYW4=|https://frl.publisso.de/adhoc/uri/Vm9nZWwsIEJvYiBPLg==|https://frl.publisso.de/adhoc/uri/V8O2bHdlciwgV29sZmdhbmc=|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLCBGcmFuaw==|https://frl.publisso.de/adhoc/uri/SGVua2VsLCBLYXJzdGVu|https://frl.publisso.de/adhoc/uri/TWV5ZXItTGluZGVuYmVyZywgQW5kcmVhcw==|https://frl.publisso.de/adhoc/uri/RmFsa2FpLCBQZXRlcg==
1000 Hinweis
  • DeepGreen-ID: da3cc559690a43f2b0960f8c749fa72e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469542.rdf
1000 Erstellt am 2023-11-17T23:39:34.548+0100
1000 Erstellt von 322
1000 beschreibt frl:6469542
1000 Zuletzt bearbeitet Fri Dec 01 10:02:28 CET 2023
1000 Objekt bearb. Fri Dec 01 10:02:28 CET 2023
1000 Vgl. frl:6469542
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469542 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source